Faktu 

72,00 EGP

8 rectal suppositories

Compare
Category:

Description

Trade name:

Faktu

Compound:

Each suppository contains:

Polycresuline 100 mg.

Cinchocaine hydrochloride 2.5 mg.

Excipients: sodium hydroxide, colloidal silicon dioxide anhydrous, microcrystalline cellulose, soy phospholipids, edetate, hard fat (Witepsol H12 and Witepsol W31).

Properties:

Polycresulin is a polymerized organic acid with selective protein properties. The pH of the preparation is 4.0. It causes contraction of small blood vessels, leaving healthy tissues unchanged, which immediately stops bleeding. In addition, it increases local blood flow, which accelerates the healing process. The bactericidal effect prevents the accumulation of pathogenic microorganisms and inflammation. Local surface anesthetic Cinchocaine relieves pain and itching in the anorectal area.

Indications:

For the treatment of internal hemorrhoids, especially in the presence of inflammatory symptoms and bleeding; anal fissures, anal itching; anal eczema; also the treatment of wounds and healing after proctological operations.

Method of administration and dosage:

2-3 suppositories are administered daily (1 suppository after each bowel movement and at night). After symptoms improve, treatment can be continued at a dose of 1 suppository per day. The use and safety of the suppository in children and adolescents has not been tested.

Contraindications:

Hypersensitivity to the active substances, any of the excipients or other local anesthetics.

Precautionary measures.

If allergic reactions occur, the drug should be discontinued.

Side effects:

Skin and subcutaneous tissue: sometimes unpleasant sensations (e.g. burning, itching), which usually disappear after a short time. Very rare: allergic contact sensitization (erythema with papules, itching). In this case, treatment should be discontinued. Immune system disorders very rare: allergic reactions, including general reactions (angioedema, laryngeal edema, urticaria, etc.) and generalized reactions: anaphylaxis. If any symptoms of adverse reactions, which have been mentioned or others, occur, stop using the drug and consult a doctor.

Pregnancy and lactation: There are no clinical data on use in pregnant women. Use during pregnancy or breastfeeding with caution and under medical supervision.

Storage method:

Store at a temperature not exceeding 25 degrees, out of reach of children.

Package:

The cardboard box contains 2 blisters of 4 suppositories and paper instructions.